The CCR5 receptor antagonist maraviroc reduces viral load in patients with HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

HIV Co-Receptor CCR5: Structure and Interactions with Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete   Huitema Alwin DR   Mulder Jan Willem  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1504-1514

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 Chemokine Receptor Antagonist

By  

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1201-1208

Bentham Science Publishers

Access to resources Recommend Favorite